Novartis Pharmaceuticals Canada Inc.385 Bouchard BlvdDorval, QuebecH9S 1A9
(514) 631-6775 By e-mail : Response times may vary during holidays.Resident of Canada
Novartis International AG Investor Relations P.O. Box CH-4002 Basel Switzerland
+41 61 324 79 44 firstname.lastname@example.org
Department of CommunicationsNovartis Pharmaceuticals Canada Inc.385 Bouchard Blvd.Dorval, Quebec H9S 1A9
Diseases & Conditions home
About Novartis home
Research & Development
Grants & Donations
Access to excellence
Novartis is recognized worldwide for bringing to market innovative medicines with improved efficacy and fewer side-effects.
Alcon provides products to help people of all ages maintain their vision, including prescription and over-the-counter treatments for a variety of age-related eye conditions and diseases.
Sandoz is a global leader in offering high-quality generic treatment options following the expiry of patents.
Receive media releases via e-mail
Subscribe to Novartis featured news